Summary
In Arnelien, [a case involving the same decongestant that caused the stroke in Engstroni], the plaintiff was a Canadian citizen who suffered a stroke after ingesting a cold tablet marketed by defendant, SmithKline Beecham. Significantly, the specific medication, purchased by the plaintiff and ingested in Canada, was marketed only in Canada, and was subject to Canadian regulatory laws.
Summary of this case from Hunter v. Shire US, Inc.Opinion
No. 650 EDA 2005.
January 24, 2006.
Appeal from 002275 July Term 2002 (Philadelphia).
Affirmed.